Mindfulness practice for patients with endometrial and cervical cancer
Mindfulness Practice in Endometrial and Cervical Cancers With Smartphone Applications (MECCA)
This study is testing whether using a mindfulness app can help women with endometrial or cervical cancer feel less stressed and anxious before their surgery or treatment.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 120 (estimated) |
| Ages | 18 Years to 90 Years |
| Sex | Female |
| Sponsor | St. Louis University Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (St Louis, Missouri) |
| Trial ID | NCT04512144 on ClinicalTrials.gov |
What this trial studies
This study examines the effects of using the Headspace smartphone application for mindfulness on patients diagnosed with endometrial or cervical cancer who are preparing for surgery or chemoradiation. Participants will be randomized to either use the app or not prior to their treatment. The goal is to assess whether mindfulness can help manage stress, anxiety, and improve quality of life while potentially reducing opioid use. The study builds on existing literature that suggests mindfulness can have positive effects on cancer patients' well-being.
Who should consider this trial
Good fit: Ideal candidates are individuals newly diagnosed with endometrial cancer undergoing surgery or cervical cancer receiving chemoradiation who have access to a smartphone.
Not a fit: Patients who do not speak English, lack access to a smartphone, or are currently using the Headspace application may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could enhance the quality of life for cancer patients and reduce their reliance on opioids.
How similar studies have performed: Previous studies have shown positive outcomes with mindfulness interventions in cancer patients, suggesting this approach may be effective.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * New diagnosis of either 1) endometrial cancer undergoing surgery or 2) cervical cancer undergoing chemo-sensitizing radiation * Access to a smartphone Exclusion Criteria: * Non-English speaking * No access to smartphone * Current use of Headspace application
Where this trial is running
St Louis, Missouri
- Saint Louis University — St Louis, Missouri, United States (Recruiting)
Study contacts
- Principal investigator: Shannon Grabosch, MD — St. Louis University
- Study coordinator: Shannon Grabosch, MD
- Email: shannon.grabosch@health.slu.edu
- Phone: 3147818605
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.